273 related articles for article (PubMed ID: 36353633)
1. Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Sosa Cuevas E; Valladeau-Guilemond J; Mouret S; Roubinet B; de Fraipont F; Landemarre L; Charles J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2022; 13():1040600. PubMed ID: 36353633
[TBL] [Abstract][Full Text] [Related]
2. Melanoma tumour-derived glycans hijack dendritic cell subsets through C-type lectin receptor binding.
Niveau C; Sosa Cuevas E; Roubinet B; Pezet M; Thépaut M; Mouret S; Charles J; Fieschi F; Landemarre L; Chaperot L; Saas P; Aspord C
Immunology; 2024 Feb; 171(2):286-311. PubMed ID: 37991344
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs.
Ouaguia L; Dufeu-Duchesne T; Leroy V; Decaens T; Reiser JB; Sosa Cuevas E; Durantel D; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Clin Transl Immunology; 2020; 9(12):e1208. PubMed ID: 33312564
[TBL] [Abstract][Full Text] [Related]
4. The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Sosa Cuevas E; Roubinet B; Mouret S; Thépaut M; de Fraipont F; Charles J; Fieschi F; Landemarre L; Chaperot L; Aspord C
Front Immunol; 2023; 14():1120434. PubMed ID: 36891308
[TBL] [Abstract][Full Text] [Related]
5. BDCA1
Sosa Cuevas E; Ouaguia L; Mouret S; Charles J; De Fraipont F; Manches O; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Clin Transl Immunology; 2020; 9(11):e1190. PubMed ID: 33282290
[TBL] [Abstract][Full Text] [Related]
6. Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection.
Ouaguia L; Leroy V; Dufeu-Duchesne T; Durantel D; Decaens T; Hubert M; Valladeau-Guilemond J; Bendriss-Vermare N; Chaperot L; Aspord C
Front Immunol; 2019; 10():112. PubMed ID: 30778353
[No Abstract] [Full Text] [Related]
7. Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation.
Sosa Cuevas E; Saas P; Aspord C
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190135
[TBL] [Abstract][Full Text] [Related]
8. From structure to function - Ligand recognition by myeloid C-type lectin receptors.
Fischer S; Stegmann F; Gnanapragassam VS; Lepenies B
Comput Struct Biotechnol J; 2022; 20():5790-5812. PubMed ID: 36382179
[TBL] [Abstract][Full Text] [Related]
9. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
10. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production.
Meyer-Wentrup F; Benitez-Ribas D; Tacken PJ; Punt CJ; Figdor CG; de Vries IJ; Adema GJ
Blood; 2008 Apr; 111(8):4245-53. PubMed ID: 18258799
[TBL] [Abstract][Full Text] [Related]
11. Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets.
Lundberg K; Rydnert F; Broos S; Andersson M; Greiff L; Lindstedt M
PLoS One; 2016; 11(2):e0148838. PubMed ID: 26863539
[TBL] [Abstract][Full Text] [Related]
12. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
[TBL] [Abstract][Full Text] [Related]
13. Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80
Sosa Cuevas E; Bendriss-Vermare N; Mouret S; De Fraipont F; Charles J; Valladeau-Guilemond J; Chaperot L; Aspord C
Clin Transl Immunology; 2022; 11(5):e1382. PubMed ID: 35517992
[TBL] [Abstract][Full Text] [Related]
14. C-type lectins on dendritic cells: key modulators for the induction of immune responses.
van Kooyk Y
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1478-81. PubMed ID: 19021579
[TBL] [Abstract][Full Text] [Related]
15. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells.
Hsu SC; Chen CH; Tsai SH; Kawasaki H; Hung CH; Chu YT; Chang HW; Zhou Y; Fu J; Plunkett B; Su SN; Vieths S; Lee RT; Lee YC; Huang SK
J Biol Chem; 2010 Mar; 285(11):7903-10. PubMed ID: 20080962
[TBL] [Abstract][Full Text] [Related]
17. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells.
Unger WW; van Beelen AJ; Bruijns SC; Joshi M; Fehres CM; van Bloois L; Verstege MI; Ambrosini M; Kalay H; Nazmi K; Bolscher JG; Hooijberg E; de Gruijl TD; Storm G; van Kooyk Y
J Control Release; 2012 May; 160(1):88-95. PubMed ID: 22366522
[TBL] [Abstract][Full Text] [Related]
18. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer.
Jin W; Li C; Du T; Hu K; Huang X; Hu Q
Virology; 2014 Jun; 458-459():83-92. PubMed ID: 24928041
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.
Besson S; Laurin D; Chauvière C; Thépaut M; Kleman JP; Pezet M; Manches O; Fieschi F; Aspord C; Fender P
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359404
[TBL] [Abstract][Full Text] [Related]
20. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN.
Meyer S; van Liempt E; Imberty A; van Kooyk Y; Geyer H; Geyer R; van Die I
J Biol Chem; 2005 Nov; 280(45):37349-59. PubMed ID: 16155001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
